Leerink Partnrs Has Positive Estimate for WBA Q2 Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Equities research analysts at Leerink Partnrs increased their Q2 2025 earnings estimates for shares of Walgreens Boots Alliance in a report released on Tuesday, December 17th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings of $0.49 per share for the quarter, up from their prior estimate of $0.47. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $1.53 per share.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. During the same period last year, the company posted $0.67 EPS.

WBA has been the subject of a number of other research reports. Royal Bank of Canada lowered their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday, December 4th. Barclays increased their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. TD Cowen decreased their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. UBS Group increased their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Finally, Jefferies Financial Group decreased their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $9.55 on Thursday. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The stock has a market cap of $8.26 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.36 and a beta of 0.66. The business’s 50 day moving average price is $9.34 and its 200-day moving average price is $10.55. Walgreens Boots Alliance has a 52 week low of $8.08 and a 52 week high of $27.05.

Institutional Trading of Walgreens Boots Alliance

Several large investors have recently added to or reduced their stakes in WBA. Assenagon Asset Management S.A. increased its position in Walgreens Boots Alliance by 4.0% in the second quarter. Assenagon Asset Management S.A. now owns 27,699 shares of the pharmacy operator’s stock worth $335,000 after buying an additional 1,069 shares in the last quarter. Blue Trust Inc. increased its holdings in Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares in the last quarter. Hennessy Advisors Inc. raised its stake in Walgreens Boots Alliance by 16.6% during the 2nd quarter. Hennessy Advisors Inc. now owns 205,400 shares of the pharmacy operator’s stock worth $2,484,000 after acquiring an additional 29,300 shares during the period. &PARTNERS lifted its holdings in Walgreens Boots Alliance by 38.5% during the second quarter. &PARTNERS now owns 29,835 shares of the pharmacy operator’s stock valued at $361,000 after purchasing an additional 8,295 shares in the last quarter. Finally, Slagle Financial LLC bought a new position in shares of Walgreens Boots Alliance in the second quarter worth approximately $1,805,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 10.47%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.